Almost nothing in semiconductor land is cheap right now. First Solar might be the exception — and that is worth paying attention to, even if you have never thought of a solar panel manufacturer as a chip stock.

First Solar trades at 12.7x forward earnings and 12.7x forward free cash flow. It carries over $2.4 billion in cash with almost no debt. It just reported record Q1 2026 revenue of just over $1 billion, up 24% year over year, with expanding profit margins. It manufactures domestically in five US facilities — a sixth is under construction in South Carolina. It benefits from Inflation Reduction Act tax credits through 2029. And it has just launched a new manufacturing process called CuRe — copper replacement — that increases panel lifetime energy yield by up to 8% and extends panel lifespan.

Everything checks out. Until you look at the guidance and the backlog.

Full year 2026 revenue is expected to come in flat to slightly down versus 2025. The order backlog, which peaked above 70 gigawatts in 2023, has now declined to under 48 gigawatts. First Solar is working through existing orders faster than it is winning new ones. A sizable cancellation from customer LightSource BP in 2024 and 2025 accelerated that decline. These are the hallmarks of a value trap — a stock that looks cheap because the future earning power is genuinely uncertain, not because the market has mispriced it.

The potential inflection point is a pending Section 232 investigation into whether crystalline silicon solar panel imports — primarily from China, where state-subsidized price dumping has been a recurring competitive tactic — constitute a national security risk. If the ruling lands in Q2 2026 and tariff protections follow, First Solar's order book could refill rapidly. If it does not, the backlog decline continues and the cheap valuation has every reason to stay cheap.

CSI walks through the full picture: the thin-film cadmium telluride technology edge, the CuRe manufacturing upgrade, the domestic supply chain advantage, the backlog reality, and a reverse DCF that shows the bar First Solar needs to clear is genuinely low — only 7% annual profit growth over five years with a 0% terminal rate gets you to today's price. The conclusion is honest: mildly interested, but the hallmarks of a value trap are present. Patience is the strategy.

What we cover:

— Why a solar company qualifies as a chip stock — and where First Solar fits in the supply chain

— First Solar Q1 2026: $1B+ revenue, record margins, $2.4B cash, minimal debt

— Thin-film cadmium telluride vs. crystalline silicon — the technology difference that matters

— The CURE manufacturing process: launching now in Ohio, targeted across all facilities

— Domestic US manufacturing as a competitive and geopolitical advantage

— The guidance problem: flat to down revenue in 2026

— The backlog decline: from 70GW in 2023 to under 48GW and still falling

— Section 232 tariff investigation — the binary catalyst expected Q2 2026

— Reverse DCF: 12.7x earnings, 7% growth, 0% terminal rate

— CSI verdict: mildly interested, but patient — the value trap signs are real

Disclosure: Nick and Kasey do not currently hold First Solar. This content is for general information only and is not individual investment advice. All investing involves risk.

chipstockinvestor.com